A top UW-Madison researcher who has worked for the Pfizer drug company said Tuesday that firms using stem cells to test and create new drugs could generate more than $3.6 billion in revenues by 2020.
And Wisconsin could be home to new companies doing doing that work, thanks to a wealth of scientific experts here, said Dr. Gabriela Cezar, who spoke at a Wisconsin Innovation Network luncheon.